United States· US:0143-9742_9a99920c-c630-487a-a1fc-5289eeaf451b
Oxytocin
A oxytocin product containing oxytocin, registered in United States by West-Ward Pharmaceuticals Corp. The same ATC class is registered in 16 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Oxytocin is registered in 16 of 19 countries.
Countries holding a registration under ATC H01BB02 (oxytocin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Oxytocin · ATC H01BB02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OXYTOCIN
- Manufacturer
- West-Ward Pharmaceuticals Corp
- Country
- United States (US)
- ATC code
- H01BB02
- ATC class
- Oxytocin
- Defined daily dose
- 15 E, N
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11014397422525 VIAL in 1 CARTON (0143-9742-25) / 10 mL in 1 VIAL (0143-9742-01)
- ndc110143-9742-25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
303 interactions on record for oxytocin.
Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Oxytocin · interactions on record
303 records
- 71 severe
- 228 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Oxytocin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomOxytocin 10units/1ml concentrate for solution for infusion ampoulesPanpharma UK Ltd
- FinlandOxytocin OrifarmOrifarm Generics A/S
- NorwayOxytocin cd pharmaCD Pharmaceuticals
- SwedenOxygrindeks 8,3 mikrogram/ml Injektions-/infusionsvätska, lösningAS GRINDEKS
- CzechiaOFOSTAS GRINDEKS, Riga
- NetherlandsOxytocine Eureco-Pharma 5 IE/ml, concentraat voor oplossing voor infusie, oplossing voor injectieEureco-Pharma B.V.
- IrelandOfost 10 IU/ml concentrate for solution for infusion or solution for intramuscular injectionAS Grindeks
- CanadaOXY-20 NWRAFTER 8 PRODUCTS INC
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Oxytocin Grindeks, Syntocinon
- Belgium · Oxytocin Grindeks, Syntocinon
- Bulgaria · Окситоцин Pихtep
- Cyprus · Syntocinon
- Czechia · Ofost, Oxytocin Avmc
- Germany · Oxytocin Hexal, Oxytocin Panpharma
- Denmark · Oxytocin Orifarm, Syntocinon
- Estonia · Oxytocin Grindeks
- Spain · Oxitocina Grindeks, Syntocinon
- Finland · Oxytocin Orifarm, Syntocinon
- France · Oxytocine Ever Pharma, Oxytocine Grindeks
- United Kingdom (Northern Ireland) · Oxytocin, Oxytocin Hameln Pharma
- Greece · Oxytocin Gap
- Croatia · Syntocinon
- Hungary · Oxytocin Grindeks, Oxytocin Panpharma
- Ireland · Ofost, Oxytocin Pinewood Laboratories
- Iceland · Syntocinon
- Italy · Ossitocina Grindeks, Syntocinon
- Lithuania · Ofost, Oxytocin Grindeks
- Latvia · Ofost, Oxytocin Grindeks
- Malta · Oxytocin Wockhardt, Syntocinon
- Netherlands · Syntocinon
- Norway · Oxytocin Cd Pharma, Oxytocin Orifarm
- Poland · Oxytocin Grindeks, Oxytocin Grindex
- Portugal · Oxitocina Generis, Oxitocina Grindeks
- Romania · Ofost, Oxitocină Panpharma
- Sweden · Oxytocin Cd Pharma, Oxytocin Grindeks
- Slovenia · Ofost, Syntocinon
- Slovakia · Ofost, Oxygrindeks
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6541d051-7dd5-4791-a19e-58093b814eaf GET /v1/drugs/6541d051-7dd5-4791-a19e-58093b814eaf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAMUSCULAR; INTRAVENOUS",
"source": "ndc",
"strength": "10",
"substance": "OXYTOCIN",
"productndc": "0143-9742",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "[USP'U]/mL",
"application_number": "ANDA200219",
"marketing_category": "ANDA"
}See everything about oxytocin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.